(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has risen 16.95% since its last report, with 1.27 million shares sold short, which is 1.38% of all regular shares available for trading. It would take traders 2.08 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, Regeneron Pharmaceuticals's peer group average for short interest as a percentage of float is 3.53%, which means the company has less short interest than most of its peers.
August 04, 2023 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals's short interest has increased, indicating a bearish sentiment among investors. However, its short interest is less than its peers.
An increase in short interest indicates that more investors are betting that the stock price will fall. However, the fact that Regeneron's short interest is less than its peers could mean that the bearish sentiment is not as strong as it is for other companies in the same industry.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100